Stock listing
IMM Stock Price, News, Filings & Events — Immupharma Plc
Selected listing: IMM · LSE · GBX · GB
This page tracks Immupharma Plc's IMM:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IMM:LSE. IMM:LSE is the stock-level entry point for investors researching Immupharma Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Immupharma Plc is a public company listed on the UK market under the ticker IMM, with a market capitalization of approximately £33.2 million. The company focuses on developing innovative pharmaceutical products, particularly in the field of immunology. Immupharma aims to address unmet medical needs through its research and development efforts.
- Ticker
- IMM:LSE
- Asset type
- Stock
- Market cap
- $29.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- LSE
- Currency
- GBX
Immupharma Plc IMM:LSE stock context
This page tracks Immupharma Plc's IMM:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IMM:LSE. IMM:LSE is the stock-level entry point for investors researching Immupharma Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Immupharma Plc is a public company listed on the UK market under the ticker IMM, with a market capitalization of approximately £33.2 million. The company focuses on developing innovative pharmaceutical products, particularly in the field of immunology. Immupharma aims to address unmet medical needs through its research and development efforts.
Latest news from Immupharma Plc
Immupharma Plc earnings calls
Research Immupharma Plc
Immupharma Plc investor report
Review AI stock analysis and investor report context for IMM:LSE.
Immupharma Plc company profile
View the public company page for Immupharma Plc on 6ix.
Immupharma Plc news
Read company news and market updates connected to Immupharma Plc.
Immupharma Plc investor events
Find investor webinars, events, and replay context for Immupharma Plc.
Alternate listings
A0BMC4:LSX
DE · EUR
Alternate listing for Immupharma Plc; the primary context on this page is IMM:LSE.
A0BMC4:LS
DE · EUR
Alternate listing for Immupharma Plc; the primary context on this page is IMM:LSE.
25I:GETTEX
DE · EUR
Alternate listing for Immupharma Plc; the primary context on this page is IMM:LSE.
25I:FWB
DE · EUR
Alternate listing for Immupharma Plc; the primary context on this page is IMM:LSE.
IMML:TURQUOISE
GB · GBX
Alternate listing for Immupharma Plc; the primary context on this page is IMM:LSE.
IMM.GB:AQUIS
GB · GBX
Alternate listing for Immupharma Plc; the primary context on this page is IMM:LSE.
25I:MUN
DE · EUR
Alternate listing for Immupharma Plc; the primary context on this page is IMM:LSE.
25I:SWB
DE · EUR
Alternate listing for Immupharma Plc; the primary context on this page is IMM:LSE.